|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 151.87 INR | -0.93% |
|
-2.73% | -11.81% |
| Capitalization | 20TCr 219.43Cr 189.2Cr 170.79Cr 163.88Cr 298.83Cr 312.74Cr 2.02TCr 808.86Cr 9.67TCr 823.56Cr 806Cr 35TCr | P/E ratio 2026 * |
-217x | P/E ratio 2027 * | 67.1x |
|---|---|---|---|---|---|
| Enterprise value | 25TCr 267.49Cr 230.63Cr 208.19Cr 199.77Cr 364.27Cr 381.23Cr 2.46TCr 986Cr 12TCr 1TCr 982.52Cr 42TCr | EV / Sales 2026 * |
2.76x | EV / Sales 2027 * | 2.43x |
| Free-Float |
45.03% | Yield 2026 * |
-
| Yield 2027 * | 0.18% |
Last Transcript: Piramal Pharma Limited
| 1 day | -0.93% | ||
| 1 week | -2.73% | ||
| Current month | -2.73% | ||
| 1 month | -4.33% | ||
| 3 months | -15.56% | ||
| 6 months | -24.31% | ||
| Current year | -11.81% |
| 1 week | 150.01 |  | 154.96 |
| 1 month | 150.01 | | 169.54 |
| Current year | 148.31 | | 185.04 |
| 1 year | 148.31 | | 240.95 |
| 3 years | 63.1 | | 307.9 |
| 5 years | 63.1 | | 307.9 |
| 10 years | 63.1 | | 307.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter DeYoung
CEO | Chief Executive Officer | 48 | 04/03/2020 |
Vivek Valsaraj
DFI | Director of Finance/CFO | 53 | 10/06/2020 |
Pratibha Mishra
CMP | Compliance Officer | - | 21/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 45 | - | |
| Director/Board Member | 53 | 30/03/2022 | |
Amit Soni
BRD | Director/Board Member | 58 | 09/02/2026 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.93% | -2.73% | -24.20% | +94.33% | 219.43Cr | |
| +0.72% | -5.86% | +8.50% | +210.49% | 88TCr | |
| +0.32% | -3.23% | +44.97% | +54.54% | 58TCr | |
| -0.96% | -0.85% | +9.19% | +48.19% | 41TCr | |
| -2.93% | -7.03% | +12.72% | +26.04% | 35TCr | |
| -1.25% | -5.55% | +23.92% | +55.59% | 30TCr | |
| -1.85% | -6.70% | +20.55% | +34.98% | 30TCr | |
| -0.24% | -6.49% | +23.18% | +4.22% | 29TCr | |
| +0.53% | -4.80% | +16.27% | +57.17% | 20TCr | |
| -0.83% | -3.37% | +24.03% | +77.45% | 18TCr | |
| Average | -0.74% | -4.50% | +15.91% | +66.30% | 34.91TCr | |
| Weighted average by Cap. | -0.47% | -4.59% | +19.85% | +86.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.89TCr 97Cr 83Cr 75Cr 72Cr 131.76Cr 137.89Cr 890.21Cr 356.64Cr 4.26TCr 363.12Cr 355.38Cr 15TCr | 10TCr 111.42Cr 96Cr 87Cr 83Cr 151.73Cr 158.8Cr 1.03TCr 410.71Cr 4.91TCr 418.17Cr 409.26Cr 18TCr |
| Net income | -105.23Cr -1.15Cr -98.72L -89.12L -85.51L -1.56Cr -1.63Cr -11Cr -4.22Cr -50Cr -4.3Cr -4.21Cr -180.48Cr | 299.66Cr 3.26Cr 2.81Cr 2.54Cr 2.44Cr 4.44Cr 4.65Cr 30Cr 12Cr 143.7Cr 12Cr 12Cr 513.94Cr |
| Net Debt | 4.42TCr 48Cr 41Cr 37Cr 36Cr 65Cr 68Cr 442.17Cr 177.14Cr 2.12TCr 180.36Cr 176.52Cr 7.57TCr | 4.72TCr 51Cr 44Cr 40Cr 38Cr 70Cr 73Cr 472.21Cr 189.18Cr 2.26TCr 192.62Cr 188.51Cr 8.09TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | 151.87 ₹ | -0.93% | 10,38,728 |
| 05/26/05 | 153.30 ₹ | +0.65% | 12,31,271 |
| 04/26/04 | 152.31 ₹ | -0.33% | 19,21,293 |
| 02/26/02 | 152.81 ₹ | -2.13% | 20,46,239 |
| 27/26/27 | 156.13 ₹ | -3.87% | 27,89,207 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PPLPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition